“Mavacamten’s Therapeutic Impact: Cardiac-Specific Myosin Inhibition in Obstructive Hypertrophic Cardiomyopathy”. Global Cardiology, vol. 2, no. 3, Nov. 2024, https://doi.org/10.4081/cardio.2024.48.